News
Anti-Ro52 autoantibodies signal interstitial lung disease in juvenile dermatomyositis teaser
MAUI, HAWAII - And in a recent potential treatment advance, Janus kinase inhibition shows promise as a novel therapy for ILD in patients with JDM...
News
Expert discusses red flags for interstitial lung disease in pediatric rheumatology
MAUI, HAWAII – Catch lung disease early in youths with juvenile dermatomyositis or systemic juvenile idiopathic arthritis.
News
Cautionary findings on acquired immunodeficiency from anti-CD20 MS therapy
Clinicians are advised to monitor patients with MS much closer for signs of hypogammaglobulinemia and lymphopenia starting with year 2 on therapy...
News
CGRP inhibitors receive reassuring real-world safety report
“These results will be practice changing,” said Dr. Stephen D. Silberstein.
News
Substantial very late MACE risk after PCI for SIHD
Analysis of 19 prospective randomized coronary stent trials finds no plateau in MACE beyond first year.
News
COVID-19: No U.S. spike expected in pandemic-related suicidal ideation
Big Data analysis of real-time Crisis Text Line experience offers encouragement.
News
European COVID-19 insights: Try helmet CPAP
An older, relatively inexpensive form of noninvasive ventilation appears to prevent self-induced lung injury.
News
Methotrexate adherence: It’s worse than you think
MAUI, HAWAII – “This is our cornerstone drug – methotrexate – and I think it certainly applies to other medications that we’re using,” said Dr....
News
Differentiating hypersensitivity reactions to monoclonal antibodies
MAUI, HAWAII – Who to send to the allergist for desensitization.
News
HFpEF: Gender difference in sacubitril/valsartan response remains mystery
Why did women on sacubitril/valsartan get a 27% reduction in cardiovascular death and heart failure hospitalization, while the men got nothing?
News
Experts review recent winners and losers in the RA pipeline
MAUI, HAWAII – “Syk inhibition is not sick, Syk is dead.” – Dr. Roy Fleischmann
News
A case of neutrophilic eccrine hidradenitis attributed to HIV treatment
The most common causes of NEH are hematologic malignancies and some of the chemotherapeutic agents used in treating them.
News
TWILIGHT-COMPLEX: Tap ticagrelor monotherapy early after complex PCI
“We found that the aspirin just doesn’t add that much, even in complex patients – just bleeding complications, for the most part.”